Objective To observe the neuroprotection of Puerarin on cerebral ischemia reperfusion injury and
investigate its effect on the expression of estrogen receptor α (ER-α) , hypoxia inducible factor-1
(HIF-1α) and related inflammatory cytokines.
Methods Mice were randomly divided into a sham group, a solvent-control group and three
Puerarin-treated groups with different doses (100, 250, 500 mg·kg-1). Middle cerebral artery
occlusion (MCAO) model was made and then the infarct volume, water content and neurological
scores were evaluated after 2 h ischemia and 24 h reperfusion. Western blot was used to determine
the expression of ER-α and HIF-1α after 2 h, 6 h, 12 h, 24 h reperfusion respectively. Both Western
blot and ELISA were used to determine the effect of Puerarin on the expression of ER-α, HIF-1α and related inflammatory cytokines such as tumor necrosis factor-α (TNF- α), interleukin-1β (IL-1β)
and interleukin-6 (IL-6) in 2 h ischemia and 12 h reperfusion mice.
Results Compared with solvent-control group, Puerarin reduced the infarct volume [low dose
group (29.6±3.6)%, medium dose group (15.2±3.9)%, high dose group (8.2±2.1)% vs control group
(39.3±5.0)%] and water content [low dose group (84.9±8.8)%, medium dose group (83.7±8.2)%,
high dose group (80.9±8.7)% vs control group (85.3±10.2)%], which had significant difference. It
also activated ER-α and suppressed HIF-1α. In addition, medium and high dose of Puerarin further
inhibited TNF-α [(420.7± 27.2) μg·g-1, (379.6±23.9) μg·g-1], IL-1β [(211.8±19.2) μg·g-1, (182.4±13.5)
μg·g-1] and IL-6 [(111.2±9.1) μg·g-1, (104.1±12.4) μg·g-1] respectively compared to solvent control
group [TNF-α (505.8±36.7) μg·g-1; IL-1β (291.6±21.8) μg·g-1; IL-6 (138.4±11.7) μg·g-1] in 2 h
ischemia and 12 h reperfusion mice.
Conclusion Puerarin within certain range of doses could reduce the water content and infarct
volume of cerebral ischemia reperfusion injury. Its mechanism might be linked to activation of
ER-α, inhibition the expression of HIF-1α, and the inhibition of release of related inflammatory
cytokines such as TNF-α, IL-1β and IL-6.